CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.610
-0.120 (-4.40%)
At close: Aug 17, 2026, 4:00 PM EDT
2.600
-0.010 (-0.38%)
After-hours: Aug 17, 2026, 7:58 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $39.46 million as of August 17, 2026. Its market cap has decreased by -57.86% in one year.
Market Cap
39.46M
Enterprise Value
14.52M
1-Year Change
-57.86%
Ranking
Category
Stock Price
$2.61
ChartMarket Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $39.46M, a decrease of -8.79%. That is a compound annual growth rate of -3.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 39.46M | -46.02% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 46.55M |
| Metagenomi Therapeutics | 46.47M |
| Karyopharm Therapeutics | 45.82M |
| Grace Therapeutics | 45.44M |
| Seres Therapeutics | 45.13M |
| Filana Therapeutics | 44.12M |
| Aligos Therapeutics | 43.03M |
| Serina Therapeutics | 41.99M |